Association of hearing loss and tinnitus symptoms with health‐related quality of life among long‐term oropharyngeal cancer survivors. (13th June 2022)

• Record Type: Journal Article
• Authors: Aggarwal, Puja; Nader, Marc‐Elie; Gidley, Paul W.; Pratihar, Raj; Jivani, Shirin; Garden, Adam S.; Mott, Frank E.; Goepfert, Ryan P.; Ogboe, Christopher Wallace; Charles, Camille; Fuller, Clifton D.; Lai, Stephen Y.; Gunn, G. Brandon; Sturgis, Erich M.; Hanna, Ehab Y.; Hutcheson, Katherine A.; Shete, Sanjay
• Is Part Of: Cancer medicine. Volume 12:Number 1(2023)
• Page Start: 569
• Page End: 583
• Publication Date: 2022-06-13
• Subjects: hearing loss -- oropharyngeal cancer -- ototoxicity -- survivorship -- tinnitus; 616.994005
• DOI: 10.1002/cam4.4931
• Languages: English
• ISSNs: 2045-7634

Abstract

Abstract: Background: This study investigated the association of hearing loss and tinnitus with overall health‐related quality of life (HRQoL) among long‐term oropharyngeal cancer (OPC) survivors. Methods: This study included OPC survivors treated between 2000 and 2013 and surveyed from September 2015 to July 2016. Hearing loss and tinnitus were measured by asking survivors to rate their "difficulty with hearing loss and/or ringing in the ears" from 0 (not present) to 10 (as bad as you can imagine). Hearing loss and tinnitus scores were categorized as follows: 0 for none, 1–4 for mild, and 5–10 for moderate to severe. The primary outcome was the mean score of MD nderson Symptom Inventory Head & Neck module interference component as a HRQoL surrogate dichotomized as follows: 0 to 4 for none to mild and 5 to 10 for moderate to severe interference. Results: Among 880 OPC survivors, 35.6% (314), reported none, 39.3% (347) reported mild, and 25.1% (221) reported moderate to severe hearing loss and tinnitus. On multivariable analysis, mild (OR, 5.83; 95% CI; 1.48–22.88; p = 0.012) and moderate (OR, 30.01; 95% CI; 7.96–113.10; p < 0.001) hearing loss and tinnitus were associated with higher odds of reporting moderate to severe symptom interference scores in comparison to no hearing loss and tinnitus. This association of hearing dysfunction was consistent with all domains of HRQoL. Conclusions: Our findings provide preliminary evidence to support the need for continued audiological evaluations and surveillance to detect hearing dysfunction, to allow for early management and to alleviate the long‐term impact on QoL. Abstract : Hearing loss and tinnitus are important treatment‐associated toxicities in head and neck cancer patients and can contribute to severe decline in health‐related quality of life (HRQoL). In the current study, the authors identified an association between hearing loss and tinnitus with worse symptom distress and HRQoL among oropharyngeal cancer (OPC) survivors and this association was consistent across all domains of HRQoL. Findings suggest that preservation of audiological function to enhance HRQoL is vital among growing numbers of OPC survivors.